KYZATREX is a controlled substance (CIII) because it contains testosterone. It is not known if KYZATREX is safe or effective ...

MIAMI, FL / / December 3, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ('Telomir' or the 'Company'), an emerging leader in age-reversal science, today announced groundbreaking preclinical ...

GLP-1R injectable drugs are effective in treating obesity, but their success points to a gap in the market: oral alternatives ...

In fact, as many as 35% of people with IBD have some kind of oral manifestation of the condition, such as canker sores, the ...

Researchers have trained the AI model for diseases detection using over 5,200 images of tongues. Alterations in tongue color ...

Researchers in Nova Scotia led by Dalhousie University's Christopher McMaster have developed new treatments for superbugs — ...

Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed a Phase I clinical trial on its 2nd generation GKA candidate in U.S. at the 9th China ...

SHANGHAI, Nov 30, 2024 - (ACN Newswire) - Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism by which ...

The management of bone and joint infections has long relied on intravenous (IV) antibiotics. Still, emerging evidence ...

They've been dubbed 'game-changers' in the world of obesity, making the seemingly impossible, possible - significant weight ...

S4S explains the vital role dentists play in treating snoring and obstructive sleep apnoea (OSA), using mandibular ...

The study uncovers genetic factors driving early type 2 diabetes in South Asians, highlighting risks of insulin dependence and medication response challenges.